Lan Pham
Impact in
-
- Circadian rhythm and melatonin
-
- Chronic Myeloid Leukemia Treatments
Papers in
-
- Galectins and Cancer Biology 2
- Immune Cell Function and Interaction 2
-
- Signaling Pathways in Disease 1
- Co-authors
- Sheila Alexander (3 shared papers)Nicole Danielle Osier (3 shared papers)C. Edward Dixon (2 shared papers)Dianxu Ren (2 shared papers)Yvette P. Conley (2 shared papers)Ava M. Puccio (2 shared papers)Jiandong Chen (1 shared paper)Huiling Yang (1 shared paper)
- Journals
- Blood (5 papers)Journal of Clinical Oncology (1 paper)Cancer Research (1 paper)Clinical Cancer Research (1 paper)International Journal of Molecular Sciences (1 paper)
- Partner nations
- United StatesVietnamCzechia
In The Last Decade
Lan Pham
16 papers receiving 210 citations
Peers
Comparison fields: 5 of 52
- Endocrine and Autonomic Systems 31
- Hematology 50
- Genetics 37
- Neurology 31
- Molecular Biology 109
Countries citing papers authored by Lan Pham
This map shows the geographic impact of Lan Pham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Pham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Pham more than expected).
Fields of papers citing papers by Lan Pham
This network shows the impact of papers produced by Lan Pham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Pham. The network helps show where Lan Pham may publish in the future.
Co-authors
The 25 scholars most cited alongside Lan Pham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The proteasome inhibitor PS-341 inhibits growth and induces apoptosis in Bcr/Abl-positive cell lines sensitive and resistant to imatinib mesylate. | 2003 | 64 |
| 2 | 2007 | 45 | |
| 3 | 2018 | 44 | |
| 4 | 2017 | 22 | |
| 5 | 2000 | 13 | |
| 6 | 2020 | 9 | |
| 7 | 2016 | 8 | |
| 8 | 2016 | 3 | |
| 9 | 2015 | 2 | |
| 10 | 2023 | 1 | |
| 11 | 2018 | 1 | |
| 12 | 2016 | 1 | |
| 13 | 2015 | 1 | |
| 14 | 2016 | 1 | |
| 15 | 2004 | 1 | |
| 16 | 2004 | 1 | |
| 17 | 2024 | 0 |
About Lan Pham
Lan Pham is a scholar working on Immunology, Molecular Biology, Genetics, Pathology and Forensic Medicine and Oncology, having authored 17 papers that have together received 217 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Galectins and Cancer Biology (2 papers), CAR-T cell therapy research (2 papers), Circadian rhythm and melatonin (2 papers), Immune Cell Function and Interaction (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Signaling Pathways in Disease (1 paper). The work is most often cited by research in Endocrine and Autonomic Systems (31 citations), Hematology (50 citations), Genetics (37 citations), Neurology (31 citations) and Molecular Biology (109 citations). Lan Pham has collaborated with scholars based in United States, Vietnam and Czechia. Frequent co-authors include Sheila Alexander, Nicole Danielle Osier, C. Edward Dixon, Dianxu Ren, Yvette P. Conley, Ava M. Puccio, Jiandong Chen, Huiling Yang, Yang Hy and Mi‐Hye Lee. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cancer Research, Clinical Cancer Research and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.